![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 31
Zeitschriftenartikel
Koliogiannis, D.; Niess, H.; Koliogiannis, V; Ilmer, M.; Angele, M.; Werner, J. und Guba, M.
(2022):
Preservation of the round ligament to accommodate transient portal hypertension after major hepatectomy.
In: Langenbecks Archives of Surgery, Bd. 407, Nr. 6: S. 2393-2397
[PDF, 859kB]
Steib, C.; Guba, M. und Seidensticker, M.
(2021):
Pfortaderthrombosen – therapeutische Möglichkeiten.
In: Gastroenterologe, Bd. 16, Nr. 2: S. 79-89
Pretzsch, E.; D'Haese, J. G.; Renz, B.; Ilmer, M.; Schiergens, T.; Miksch, R. C.; Albertsmeier, M.; Guba, M.; Angele, M. K.; Werner, J. und Niess, H.
(2021):
Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis.
In: BMC Surgery, Bd. 21, Nr. 1, 98
Pretzsch, E.; D'Haese, J. G.; Renz, B.; Ilmer, M.; Schiergens, T.; Miksch, R. C.; Albertsmeier, M.; Guba, M.; Angele, M. K.; Werner, J. und Nieß, H.
(2021):
Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis.
In: BMC surgery, Bd. 21, Nr. 1, 98
[PDF, 859kB]
Pretzsch, E.; Boesch, F.; Neumann, J.; Ganschow, P.; Bazhin, A.; Guba, M.; Werner, J. und Angele, M.
(2019):
Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread.
In: Journal of Oncology, Bd. 2019, 7407190
[PDF, 1MB]
Hao, J.; Miksch, R.; Anger, H.; Zhu, T.; Bucher, J.; D'Haese, J.; Mayer, B.; Neumann, J.; Guba, M.; Werner, J.; Bazhin, A. und Schönberg, M.
(2017):
Perivascular Infiltration Of Lymphocytes Influence Of The Disease-Free Survival After Resection Of Hepatocellular Carcinoma.
In: Transplant international, Bd. 30: S. 39
Herden, U.; Strassburg, C. P.; Schöning, W. N.; Pratschke, J.; Kalff, J. C.; Manekeller, S.; Paul, A.; Schnitzbauer, A.; Linke, R.; Lorf, T.; Lehner, F.; Braun, F.; Stippel, D. L.; Sucher, R.; Schmidt, H.; Guba, M.; Rosmalen, M. van; Rogiers, X.; Samuel, U. und Nashan, B.
(2017):
Retrospective Analysis Of The Current Situation Of Liver Transplantation For HCC In Germany With Special Regard To Pre- And Posttransplant Tumour Staging.
In: Transplant international, Bd. 30: S. 8
Fischereder, M.; Friedrich, S.; Klingmüller, U.; Kauke, T.; Breidenbach, T.; Bösebeck, D.; Angelika, E.; Cohen, C.; Banas, B.; Guba, M.; Stangl, M.; Krämer, B.; Hugo, C.; Lopau, K.; Stadtler, M. und Mone, T.
(2017):
A Mutation of the Erythropoietin Receptor Correlates with Improved Function of Deceased-Donor Renal Transplants.
In: American Journal of Transplantation, Bd. 17: S. 360
Andrassy, J.; Wolf, S.; Lauseker, M.; Angele, M.; Werner, J. und Guba, M.
(2017):
(Extended) Right Split Liver Transplantation - An Analysis from the Eurotransplant Liver Follow-Up Registry.
In: Transplant international, Bd. 30: S. 39
Andrassy, J.; Guba, M.; Habicht, A.; Pascher, A.; Heller, K.; Banas, B.; Hakenberg, O.; Vogel, T.; Werner, J. und Kauke, T.
(2017):
Early conversion to a CNI-free immunosuppression with SRL after renal TX - longterm data of a multicenter trial and implications for DNDSA.
In: Transplant international, Bd. 30: S. 31
Wolf, S.; Hoffmann, V.; Habicht, A.; Kauke, T.; Werner, J.; Guba, M. und Andrassy, J.
(2017):
MTOR-Inhibitor Effect on Tumor Occurrence, BPAR and Mortality in Solid Organ Transplantation: A Systematic Review and Meta-Analysis.
In: Transplant international, Bd. 30: S. 21
Zhu, T.; Hao, J.; Bucher, J.; Guba, M.; Werner, J.; Bazhin, A. und Schönberg, M.
(2017):
Immunophenotyping of hepatocellular carcinoma patients.
In: Transplant international, Bd. 30: S. 8
Kleespies, A.; Mikhailov, M.; Khalil, P. N.; Pratschke, S.; Khandoga, A.; Stangl, M.; Illner, W. D.; Angele, M. K.; Jauch, K. W.; Guba, M.; Werner, J. und Rentsch, M.
(2017):
Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation.
In: BMC Complementary and Alternative Medicine
17:440
[PDF, 916kB]
Kleespies, A.; Mikhailov, M.; Khalil, P. N.; Pratschke, S.; Khandoga, A.; Stangl, M.; Illner, W. D.; Angele, M. K.; Jauch, K. W.; Guba, M.; Werner, J. und Rentsch, M.
(2017):
Moon phases and Moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation (vol 17, 440, 2017).
In: BMC Complementary and Alternative Medicine
17:478
[PDF, 383kB]
Eser-Valeri, D.; Gerbes, A. und Guba, M.
(2016):
AVOIDANCE OF LIVER TRANSPLANTATION IN SEVERE ALCOHOLIC LIVER DISEASE PATIENTS ABSTINENT FOR 6 MONTH.
In: Transplant international, Bd. 29: S. 49
Guba, M. und Umgelter, A.
(2016):
FORCIBLY DISPLACED PATIENTS PRESSURIZE LIVER TRANSPLANT LIST IN GERMANY.
In: Transplant international, Bd. 29: S. 49
Pratschke, S.; Rauch, Alexandra; Albertsmeier, M.; Rentsch, M.; Kirschneck, Michaela; Andrassy, J.; Thomas, M.; Hartwig, Werner; Figueras, J.; Del Rio Martin, J.; de Ruvo, N.; Werner, Jens; Guba, M.; Weniger, Maximilian und Angele, Martin Kurt
(2016):
Temporary Intraoperative Porto-Caval Shunts in Piggy-Back Liver Transplantation Reduce Intraoperative Blood Loss and Improve Postoperative Transaminases and Renal Function: A Meta-Analysis.
In: World Journal of Surgery, Bd. 40, Nr. 12: S. 2988-2998
Drefs, M.; Thomas, M.; Khandoga, A.; Andrassy, J.; Werner, J.; Guba, M. und Rentsch, M.
(2016):
TACROLIMUS PREVENTS CELL DEATH AFTER HEPATIC ISCHEMIA-REPERFUSION-INJURY.
In: Transplant international, Bd. 29: S. 45
Bucher, J.; Kripp, H.; Schoenberg, Markus B.; Bazhin, A.; Werner, J.; Guba, M. und Kauke, T.
(2016):
DEVELOPING A DONOR SPECIFIC B-CELL ELISPOT ASSAY FOR IMMUNOMONITORING AFTER TRANSPLANTATION BY MEANS OF HEPATITIS-B VACCINATION RESPONSE.
In: Transplant international, Bd. 29: S. 44
Schoenberg, Markus B.; Anger, H.; Hao, J.; Vater, A.; Bucher, J.; Lauseker, M.; Bazhin, A.; Rentsch, M.; Stangl, M.; Werner, J. und Guba, M.
(2016):
MUNICH RESECTION CRITERIA (MUCRES) AS A SELECTION CRITERION FOR RESECTION OR TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA CONFINED TO THE LIVER.
In: Transplant international, Bd. 29: S. 39
Wolf, S.; Hoffmann, V.; Werner, J.; Guba, M. und Andrassy, J.
(2016):
MALIGNANCIES UNDER MTOR-INHIBITOR BASED IMMUNOSUPPRESSION AFTER SOLID ORGAN TRANSPLANTATION - A SYSTEMATIC REVIEW AND METAANALYSIS.
In: Transplant international, Bd. 29: S. 34
Thomas, M.; Andrassy, J.; Stangl, M.; Rentsch, M.; Angele, M.; Gerbes, A.; Werner, J. und Guba, M.
(2016):
POSTOPERATIVE SERUM CHOLESTEROL- LEVELS PREDICT LONG-TERM OUTCOME AFTER LIVER TRANSPLANTATION.
In: Transplant international, Bd. 29: S. 33
Wolf, S.; Hoffmann, V.; Werner, J.; Guba, M. und Andrassy, J.
(2016):
INFECTIONS AFTER SOLID ORGAN TRANSPLANTATION: IS THERE A BENEFIT FOR MTOR-I OR CNI? A SYSTEMATIC REVIEW AND METAANALYSIS.
In: Transplant international, Bd. 29: S. 32-33
Andrassy, J.; Wolf, S.; Michael, L.; Werner, J. und Guba, M.
(2016):
SIMILAR OUTCOME FOR (E) RLL AND FULL GRAFT LIVER TRANSPLANTATION - AN ANALYSIS FROM THE EUROTRANSPLANT LIVER FOLLOW-UP REGISTRY.
In: Transplant international, Bd. 29: S. 29
Schoenberg, Markus B.; Vater, A.; Hao, J.; Anger, H.; Bucher, J.; Angele, M.; Guba, M.; Werner, J. und Rentsch, M.
(2016):
EARLY HCC IN COMPENSATED CIRRHOSIS SHOULD BE RESECTED IF POSSIBLE: A META-ANALYSIS OF TRANSPLANTATION VS. RESECTION.
In: Transplant international, Bd. 29: S. 23
Umgelter, A.; Hapfelmeier, A.; Kopp, W.; Rosmalen, M. von und Guba, M.
(2016):
Disparities in liver transplantation wait-list outcome between patients with and without exceptional meld in the Eurotransplant area.
In: Transplant international, Bd. 29: S. 7
Anger, H.; Schoenberg, Markus B.; Hao, J.; Vater, A.; Bucher, J.; Bazhin, A.; Angele, M.; Werner, J. und Guba, M.
(2016):
INDIVIDUALIZED THERAPY ALGORITHMS MAY GIVE HCC PATIENTS A GENUINE CHANCE OF CURE BY SURGICAL TREATMENT WHO WOULD OTHERWISE BE SUBJECTED TO PALLIATIVE TREATMENT.
In: Transplant international, Bd. 29: S. 7
D’Haese, Jan Goesta; Neumann, J.; Weniger, Maximilian; Pratschke, S.; Bjornsson, B.; Ardiles, V.; Chapman, W.; Hernandez-Alejandro, R.; Soubrane, O.; Robles-Campos, R.; Stojanovic, M.; Dalla Valle, R.; Chan, A. C.; Coenen, Michaela; Guba, M.; Werner, Jens; Schadde, E. und Angele, Martin Kurt
(2016):
Should ALPPS be Used for Liver Resection in Intermediate-Stage HCC?
In: Annals of Surgical Oncology, Bd. 23, Nr. 4: S. 1335-1343
Schiergens, T. S.; Luning, J.; Renz, B. W.; Thomas, M.; Pratschke, S.; Feng, H.; Lee, S. M.; Engel, Jutta; Rentsch, M.; Guba, M.; Werner, Jens und Thasler, W. E.
(2016):
Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer?
In: Journal of Gastrointestinal Surgery, Bd. 20, Nr. 6: S. 1163-1172
Andrassy, J.; Hoffmann, V. S.; Rentsch, M.; Stangl, M.; Habicht, A.; Meiser, B.; Fischereder, M.; Jauch, Karl-Walter und Guba, M.
(2012):
Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor-Based Immunosuppression? A Systematic Review and Meta-Analysis.
In: Transplantation, Bd. 94, Nr. 12: S. 1208-1217
Wimmer, C.-D..; Rentsch, M.; Crispin, Alexander; Illner, W. D.; Arbogast, H.; Graeb, C.; Jauch, K. W. und Guba, M.
(2007):
The janus face of immunosuupression - de novo malignancy after renal transplantation: The experience of the Transplantation Center Munich.
In: Kidney International, Bd. 71, Nr. 12: S. 1271-1278